BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theander E, Jacobsson LT. Relationship of Sjögren's Syndrome to Other Connective Tissue and Autoimmune Disorders. Rheumatic Disease Clinics of North America 2008;34:935-47. [DOI: 10.1016/j.rdc.2008.08.009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Vitali C. Immunopathologic differences of Sjögren’s syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther. 2011;13:233. [PMID: 21888688 DOI: 10.1186/ar3361] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
2 Bernacchi E, Neri R, Caproni M, Loggini B, Fabbri P, Bombardieri S. Annular subacute cutaneous lupus erythematosus lesions and polymyositis onset in a patient with primary Sjögren's syndrome: how should this unusual association be classified? Lupus 2013;22:312-5. [DOI: 10.1177/0961203312474703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Jensen DH, Oliveri RS, Trojahn Kølle SF, Fischer-Nielsen A, Specht L, Bardow A, Buchwald C. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:335-342.e1. [PMID: 24528792 DOI: 10.1016/j.oooo.2013.11.496] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
4 Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2012;39:9-14. [PMID: 22209352 DOI: 10.1016/j.jaut.2011.12.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
5 Huang X, Wang X, Yu D. Development and Validation of a Nomogram for Renal Involvement in Primary Sjögren Syndrome Patients: A Retrospective Analysis. Mod Rheumatol 2021:roab123. [PMID: 34888691 DOI: 10.1093/mr/roab123] [Reference Citation Analysis]
6 O’neill I, Scully C. Biologics in oral medicine: Sjogren syndrome: Biologics: Sjogren syndrome. Oral Dis 2013;19:121-7. [DOI: 10.1111/j.1601-0825.2012.01932.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
7 Ashena Z, Dashputra R, Nanavaty MA. Autoimmune Dry Eye without Significant Ocular Surface Co-Morbidities and Mental Health. Vision (Basel) 2020;4:E43. [PMID: 33050472 DOI: 10.3390/vision4040043] [Reference Citation Analysis]
8 Payet J, Belkhir R, Gottenberg JE, Bergé E, Desmoulins F, Meyer O, Mariette X, Seror R. ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome? RMD Open 2015;1:e000066. [PMID: 26509066 DOI: 10.1136/rmdopen-2015-000066] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
9 Fierabracci A. Unravelling autoimmune pathogenesis by screening random peptide libraries with human sera. Immunol Lett 2009;124:35-43. [PMID: 19375456 DOI: 10.1016/j.imlet.2009.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
10 Alani H, Henty J, Thompson N, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scandinavian Journal of Rheumatology 2018;47:141-54. [DOI: 10.1080/03009742.2017.1324909] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
11 Chen ML, Kao WM, Huang JY, Hung YM, Wei JC. Human papillomavirus infection associated with increased risk of new-onset psoriasis: a nationwide population-based cohort study. Int J Epidemiol 2020;49:786-97. [PMID: 32176290 DOI: 10.1093/ije/dyaa027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
12 Zandman-goddard G, Peeva E, Rozman Z, Ben-zvi I, Langevitz P, Shvartser Y, Amital D, Amital H, Kivity S, Lidar M, Orbach H, Shoenfeld Y. Sex and Gender Differences in Autoimmune Diseases. In: Oertelt-prigione S, Regitz-zagrosek V, editors. Sex and Gender Aspects in Clinical Medicine. London: Springer; 2012. pp. 101-24. [DOI: 10.1007/978-0-85729-832-4_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Martínez-Balzano CD, Touray S, Kopec S. Cystic Lung Disease Among Patients With Sjögren Syndrome: Frequency, Natural History, and Associated Risk Factors. Chest 2016;150:631-9. [PMID: 27231156 DOI: 10.1016/j.chest.2016.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosén A. Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.Front Immunol. 2018;9:229. [PMID: 29497420 DOI: 10.3389/fimmu.2018.00229] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
15 de Mendonça Invernici M, Finger Stadler A, Vale Nicolau G, Naval Machado MÂ, Soares de Lima AA, Compagnoni Martins M. Management of Sjogren's Syndrome Patient: A Case Report of Prosthetic Rehabilitation with 6-Year Follow-Up. Case Rep Dent 2014;2014:761251. [PMID: 25478245 DOI: 10.1155/2014/761251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
16 Liao KP, Kurreeman F, Li G, Duclos G, Murphy S, Guzman R, Cai T, Gupta N, Gainer V, Schur P, Cui J, Denny JC, Szolovits P, Churchill S, Kohane I, Karlson EW, Plenge RM. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum 2013;65:571-81. [PMID: 23233247 DOI: 10.1002/art.37801] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
17 Fineide F, Chen X, Bjellaas T, Vitelli V, Utheim TP, Jensen JL, Galtung HK. Characterization of Lipids in Saliva, Tears and Minor Salivary Glands of Sjögren's Syndrome Patients Using an HPLC/MS-Based Approach. Int J Mol Sci 2021;22:8997. [PMID: 34445702 DOI: 10.3390/ijms22168997] [Reference Citation Analysis]
18 Hollingsworth B, Senter L, Zhang X, Brock GN, Jarjour W, Nagy R, Brock P, Coombes KR, Kloos RT, Ringel MD, Sipos J, Lattimer I, Carrau R, Jhiang SM. Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients. J Clin Endocrinol Metab 2016;101:4085-93. [PMID: 27533304 DOI: 10.1210/jc.2016-1605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Luo J, Xu S, Lv Y, Huang X, Zhang H, Zhu X, Wang X. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome. Int J Rheum Dis 2019;22:182-90. [PMID: 30411528 DOI: 10.1111/1756-185X.13429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther 2010;12:R47. [PMID: 20302639 DOI: 10.1186/ar2958] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
21 Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber C, Buser A, Meyer-monard S, Tichelli A, Gratwohl A. Aplastic anemia and concomitant autoimmune diseases. Ann Hematol 2009;88:659-65. [DOI: 10.1007/s00277-008-0671-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
22 Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, Ghirardello A, Punzi L, Doria A. Overlap connective tissue disease syndromes. Autoimmun Rev 2013;12:363-73. [PMID: 22743033 DOI: 10.1016/j.autrev.2012.06.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 8.8] [Reference Citation Analysis]
23 Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis at the crossroad of polyautoimmunity. Autoimmunity Reviews 2013;12:1052-7. [DOI: 10.1016/j.autrev.2013.05.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
24 Umazume T, Thomas WM, Campbell S, Aluri H, Thotakura S, Zoukhri D, Makarenkova HP. Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells. Invest Ophthalmol Vis Sci 2015;56:8392-402. [PMID: 26747770 DOI: 10.1167/iovs.15-17477] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
25 Oftedal BE, Marthinussen MC, Erichsen MM, Tveitarås MK, Kjellesvik-Kristiansen A, Hammenfors D, Jonsson MV, Kisand K, Jonsson R, Wolff ASB. Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I. Autoimmunity 2017;50:211-22. [PMID: 28686485 DOI: 10.1080/08916934.2017.1344972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
26 Hussein SZ, Jacobsson LTH, Lindquist PG, Theander E. Pregnancy and fetal outcome in women with primary Sjogren's syndrome compared with women in the general population: a nested case-control study. Rheumatology 2011;50:1612-7. [DOI: 10.1093/rheumatology/ker077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
27 Kerr GS, Aggarwal A, McDonald-Pinkett S. A woman with rheumatoid arthritis, Sjögren's syndrome, leg ulcer, and significant weight loss. Arthritis Care Res (Hoboken) 2012;64:785-92. [PMID: 22290720 DOI: 10.1002/acr.21628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
28 Wang Y, Qin Q, Liu B, Fu Y, Lin L, Huang X, Jin X. Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome. Front Med (Lausanne) 2019;6:291. [PMID: 31921869 DOI: 10.3389/fmed.2019.00291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
29 Colapietro F, Lleo A, Generali E. Antimitochondrial Antibodies: from Bench to Bedside. Clin Rev Allergy Immunol 2021. [PMID: 34586589 DOI: 10.1007/s12016-021-08904-y] [Reference Citation Analysis]
30 Arman F, Shakeri H, Nobakht N, Rastogi A, Kamgar M. A Case of Kidney Involvement in Primary Sjögren's Syndrome. Am J Case Rep 2017;18:622-6. [PMID: 28577018 DOI: 10.12659/ajcr.903476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford) 2015;54:816-20. [PMID: 25313147 DOI: 10.1093/rheumatology/keu400] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
32 Patel R, Shahane A. The epidemiology of Sjögren's syndrome. Clin Epidemiol 2014;6:247-55. [PMID: 25114590 DOI: 10.2147/CLEP.S47399] [Cited by in Crossref: 38] [Cited by in F6Publishing: 108] [Article Influence: 4.8] [Reference Citation Analysis]
33 Lee Y, Kim M, Galor A. Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease. Clin Exp Optom 2021;:1-9. [PMID: 34369296 DOI: 10.1080/08164622.2021.1962210] [Reference Citation Analysis]
34 Parks CG, Costenbader KH, Long S, Hofmann JN, Beane FLE, Sandler DP. Pesticide use and risk of systemic autoimmune diseases in the Agricultural Health Study. Environ Res 2022;209:112862. [PMID: 35123967 DOI: 10.1016/j.envres.2022.112862] [Reference Citation Analysis]
35 Zazzetti F, Rivero MA, Duartes Noé DE, Gallacher A, Schiel A, Khoury MC, Laborde HA, Barreira JC. [Frequency of systemic manifestations in patients with primary Sjögren's syndrome in Argentina]. Reumatol Clin 2010;6:299-302. [PMID: 21794737 DOI: 10.1016/j.reuma.2010.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Coursey TG, de Paiva CS. Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. Clin Ophthalmol 2014;8:1447-58. [PMID: 25120351 DOI: 10.2147/OPTH.S35685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
37 Anitua E, de la Sen-Corcuera B, Orive G, Sánchez-Ávila RM, Heredia P, Muruzabal F, Merayo-Lloves J. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus. Expert Opin Biol Ther 2021;:1-15. [PMID: 34275392 DOI: 10.1080/14712598.2021.1945030] [Reference Citation Analysis]
38 Yang WJ, Yang YN, Cao J, Man ZH, Yuan J, Xiao X, Xing YQ. Risk Factors for Dry Eye Syndrome: A Retrospective Case-Control Study. Optom Vis Sci 2015;92:e199-205. [PMID: 25756335 DOI: 10.1097/OPX.0000000000000541] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
39 Gelfand JM. Multiple sclerosis. Multiple Sclerosis and Related Disorders. Elsevier; 2014. pp. 269-90. [DOI: 10.1016/b978-0-444-52001-2.00011-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 4.9] [Reference Citation Analysis]
40 Generali E, Costanzo A, Mainetti C, Selmi C. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome. Clin Rev Allergy Immunol 2017;53:357-70. [PMID: 28871434 DOI: 10.1007/s12016-017-8639-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
41 Moga I, Rimola J, Mozos A. [Woman 21 years old with systemic lupus erythematosus, lymphadenopathy and a monoclonal gammopathy]. Med Clin (Barc) 2010;134:547-53. [PMID: 20207370 DOI: 10.1016/j.medcli.2009.12.004] [Reference Citation Analysis]
42 Pasoto SG, Chakkour HP, Natalino RR, Viana VST, Bueno C, Lianza AC, de Andrade JL, Neto ML, Fuller R, Bonfa E. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren’s syndrome. Clin Rheumatol 2012;31:1331-8. [DOI: 10.1007/s10067-012-2019-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
43 Tashbayev B, Rusthen S, Young A, Herlofson BB, Hove LH, Singh PB, Rykke M, Aqrawi LA, Chen X, Utheim ØA, Utheim TP, Palm Ø, Jensen JL. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome. Sci Rep 2017;7:10761. [PMID: 28883442 DOI: 10.1038/s41598-017-10809-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
44 Islam NM, Bhattacharyya I, Cohen DM. Common Oral Manifestations of Systemic Disease. Otolaryngologic Clinics of North America 2011;44:161-82. [DOI: 10.1016/j.otc.2010.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
45 Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A. Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sjögren’s syndrome: two cases and a literature review. Modern Rheumatology 2014;23:365-73. [DOI: 10.3109/s10165-012-0644-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
46 Rodríguez MF, Asnal C, Gobbi CA, Pellet ACC, Herscovich N, Amitrano C, Demarchi J, Noé DD, Segura C, Caeiro F, Riscanevo N, Saurit V, Papasidero S, Alba PB, Raiti L, Cruzat V, Santiago ML, Vélez S, Salvatierra G, Juárez V, Secco A. Primary Sjögren syndrome and development of another autoimmune rheumatic disease during the follow-up. Adv Rheumatol 2022;62. [DOI: 10.1186/s42358-022-00250-7] [Reference Citation Analysis]
47 Theander L, Strömbeck B, Mandl T, Theander E. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjögren's syndrome? Rheumatology (Oxford) 2010;49:1177-83. [PMID: 20308122 DOI: 10.1093/rheumatology/keq023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
48 Chen R, Wang J, Xie Q, Xue J, Hao C. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence? Int J Rheum Dis 2021;24:1086-94. [PMID: 34223708 DOI: 10.1111/1756-185X.14168] [Reference Citation Analysis]
49 Váróczy L, Páyer E, Kádár Z, Gergely L, Miltényi Z, Magyari F, Szodoray P, Illés A. Malignant lymphomas and autoimmunity-a single center experience from Hungary. Clin Rheumatol 2012;31:219-24. [PMID: 21735057 DOI: 10.1007/s10067-011-1807-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
50 Vrancken AF, Said G. Vasculitic neuropathy. Peripheral Nerve Disorders. Elsevier; 2013. pp. 463-83. [DOI: 10.1016/b978-0-444-52902-2.00026-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
51 Zhang X, Yun JS, Han D, Yook JI, Kim HS, Cho ES. TGF-β Pathway in Salivary Gland Fibrosis. Int J Mol Sci 2020;21:E9138. [PMID: 33266300 DOI: 10.3390/ijms21239138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Evren Kemer O. Dry Eye in Rheumatoid Arthritis. International Ophthalmology Clinics 2017;57:89-99. [DOI: 10.1097/iio.0000000000000166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
53 Nocturne G. [Sjögren's syndrome update: Clinical and therapeutic aspects]. Rev Med Interne 2019;40:433-9. [PMID: 31027874 DOI: 10.1016/j.revmed.2019.03.329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Sah RP, Chari ST. Clinical hypothyroidism in autoimmune pancreatitis. Pancreas. 2010;39:1114-1116. [PMID: 20861701 DOI: 10.1097/mpa.0b013e3181e2188a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
55 Padern G, Duflos C, Ferreira R, Assou S, Guilpain P, Maria ATJ, Goulabchand R, Galea P, Jurtela M, Jorgensen C, Pers YM. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome. Front Immunol 2021;12:631539. [PMID: 33708222 DOI: 10.3389/fimmu.2021.631539] [Reference Citation Analysis]
56 Sherif NM, Arafa MM, Ibrahim SE, Moussa SG. CXC ligand 13 in rheumatoid arthritis and its relation to secondary Sjögren’s syndrome. The Egyptian Rheumatologist 2013;35:121-6. [DOI: 10.1016/j.ejr.2013.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
57 Amador-patarroyo MJ, Arbelaez JG, Mantilla RD, Rodriguez-rodriguez A, Cárdenas-roldán J, Pineda-tamayo R, Guarin MR, Kleine LL, Rojas-villarraga A, Anaya J. Sjögren’s syndrome at the crossroad of polyautoimmunity. Journal of Autoimmunity 2012;39:199-205. [DOI: 10.1016/j.jaut.2012.05.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
58 Amer M, Elverdin JC, Fernández-Solari J, Medina VA, Chiarenza AP, Vacas MI. Reduced methacholine-induced submandibular salivary secretion in rats with experimental periodontitis. Arch Oral Biol 2011;56:421-7. [PMID: 21145037 DOI: 10.1016/j.archoralbio.2010.11.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
59 Spinato S, Soardi CM, Zane AM. A Mandibular Implant-Supported Fixed Complete Dental Prosthesis in a Patient With Sjogren Syndrome: Case Report. Implant Dentistry 2010;19:178-83. [DOI: 10.1097/id.0b013e3181dbe081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
60 Diaz-Gallo LM, Gourh P, Broen J, Simeon C, Fonollosa V, Ortego-Centeno N, Agarwal S, Vonk MC, Coenen M, Riemekasten G, Hunzelmann N, Hesselstrand R, Tan FK, Reveille JD, Assassi S, García-Hernandez FJ, Carreira P, Camps MT, Fernandez-Nebro A, de la Peña PG, Nearney T, Hilda D, González-Gay MA, Airo P, Beretta L, Scorza R, Herrick A, Worthington J, Pros A, Gómez-Gracia I, Trapiella L, Espinosa G, Castellvi I, Witte T, de Keyser F, Vanthuyne M, Mayes MD, Radstake TR, Arnett FC, Martin J, Rueda B. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis 2011;70:454-62. [PMID: 21131644 DOI: 10.1136/ard.2010.130138] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
61 Antero DC, Parra AG, Miyazaki FH, Gehlen M, Skare TL. Secondary Sjögren's syndrome and disease activity of rheumatoid arthritis. Revista da Associação Médica Brasileira 2011;57:319-22. [DOI: 10.1590/s0104-42302011000300015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
62 Stoian M. Renal Involvement in Sjogren S Syndrome. Internal Medicine 2022;19:115-22. [DOI: 10.2478/inmed-2022-0203] [Reference Citation Analysis]
63 Sanchez-avila RM, Merayo-lloves J, Riestra AC, Anitua E, Muruzabal F, Orive G, Fernández-vega L. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome. Journal of Ocular Pharmacology and Therapeutics 2017;33:391-9. [DOI: 10.1089/jop.2016.0166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
64 Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya JM. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis 2012;2012:254319. [PMID: 22454759 DOI: 10.1155/2012/254319] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]